SRRA
Price:
$54.99
Market Cap:
$0
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally bioavailable Janus kinase 1 (JAK 1), JAK2, and Activin A receptor type 1 (ACVR1) inhibitor. The company also develops SRA515, a selective bromodomain-containing protein 4 inhibitor; and SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1. It has the license agreements with Carna Biosciences, Inc. to develop and commercialize SRA141, a small molecule kinase inhibitor targeting Cdc7; AstraZeneca AB; and CRT Pione...[Read more]
Industry
Biotechnology
IPO Date
2015-07-16
Stock Exchange
NASDAQ
Ticker
SRRA
According to Sierra Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.34. This represents a change of -35.01% compared to the average of 12.83 of the last 4 quarters.
The mean historical Current Ratio of Sierra Oncology, Inc. over the last ten years is 11.44. The current 8.34 Current Ratio has changed 7.19% with respect to the historical average. Over the past ten years (40 quarters), SRRA's Current Ratio was at its highest in in the September 2015 quarter at 41.73. The Current Ratio was at its lowest in in the March 2014 quarter at 0.
Average
11.44
Median
11.38
Minimum
2.32
Maximum
20.53
Discovering the peaks and valleys of Sierra Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 592.46%
Maximum Annual Current Ratio = 20.53
Minimum Annual Increase = -78.46%
Minimum Annual Current Ratio = 2.32
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 8.34 | -26.78% |
| 2020 | 11.38 | 390.66% |
| 2019 | 2.32 | -78.46% |
| 2018 | 10.77 | -20.90% |
| 2017 | 13.61 | -4.69% |
| 2016 | 14.28 | -30.42% |
| 2015 | 20.53 | 8.26% |
| 2014 | 18.96 | 592.46% |
The current Current Ratio of Sierra Oncology, Inc. (SRRA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.35
5-year avg
9.28
10-year avg
11.44
Sierra Oncology, Inc.’s Current Ratio is less than CinCor Pharma, Inc. (8.53), greater than POINT Biopharma Global Inc. (6.66), less than EQRx, Inc. (27.51), greater than CTI BioPharma Corp. (1.23), less than VectivBio Holding AG (9.14), greater than Gracell Biotechnologies Inc. (6.78), less than Ethzilla Corp. (10.07), less than Verve Therapeutics, Inc. (9.84), greater than Albireo Pharma, Inc. (5.93),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.53 | $1.27B | |
| 6.66 | $1.33B | |
| 27.51 | $1.14B | |
| 1.23 | $1.20B | |
| 9.14 | $1.06B | |
| 6.78 | $989.87M | |
| 10.07 | $188.33M | |
| 9.84 | $994.04M | |
| 5.93 | $915.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sierra Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sierra Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sierra Oncology, Inc.'s Current Ratio?
How is the Current Ratio calculated for Sierra Oncology, Inc. (SRRA)?
What is the highest Current Ratio for Sierra Oncology, Inc. (SRRA)?
What is the 3-year average Current Ratio for Sierra Oncology, Inc. (SRRA)?
What is the 5-year average Current Ratio for Sierra Oncology, Inc. (SRRA)?
How does the current Current Ratio for Sierra Oncology, Inc. (SRRA) compare to its historical average?